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Objective: To develop and validate a scale to measure patients’ trust in pharmacists for use as 
an outcomes predictor in pharmacoeconomic and pharmaceutical care studies.
Methods: Literature review, study team discussion and focus group discussions were conducted 
to generate items of a candidate version to be pilot-tested for content validity. An amended 
candidate version was then tested among eligible Singaporeans across different ethnic and age 
groups. Score distributions were assessed for discriminatory power and item analyses for ﬁ  nal-
izing items. Exploratory factor analysis was used to identify dimensionality and homogeneous 
items. Cronbach’s alpha was measured for internal consistency and Pearson’s correlation coef-
ﬁ  cients for convergent validity.
Results: Eighteen items were generated with good variability (SD   1.0) and symmetry (means 
ranged from −1 to 1) for score distribution. After minor changes to improve content clarity, 
the amended questionnaire was self-administered among 1196 respondents [mean (SD) age: 
38.6 (14.9) years, 51.6% female, 87%  6 years of education]. Six items were dropped due to 
inadequate item-total correlation coefﬁ  cients, leaving 12-item scale for factor analysis. Three 
factors (“benevolence”, “technical competence” and “global trust”) were identiﬁ  ed, accounting 
for 55% of the total variance. Cronbach’s alpha was 0.83, indicating high internal consistency. 
Convergent validity was demonstrated by statistically signiﬁ  cant positive correlations between 
trust and patients’ satisfaction with pharmacists’ service (r = 0.54), returning for care (r = 0.30) 
and preference of medical decision-making pattern (r = 0.16).
Conclusion: The 12-item trust in pharmacists scale demonstrated high reliability and conver-
gent validity. Further studies among other populations are suggested to conﬁ  rm the robustness 
and even improve the current scale.
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Introduction
With the increasing emphasis on pharmaceutical care in the practice of pharmacy, the 
roles of pharmacists have been undergoing vigorous expansion. Studies have shown 
that pharmaceutical care contributed to less drug-related morbidities and mortalities, 
improved clinical outcomes and health-related quality of life, and lower medical 
costs.1–3 A key success factor in the pharmaceutical care is the quality of patient-
pharmacist relationship. In such relationship, patients grant authority to pharmacists 
to manage their health and well-being. In turn, pharmacists accept responsibility to 
take care of the well-being of the patients.1,4 Because of the vulnerability of patients 
and uncertainties of outcomes, patient-pharmacist relationship is largely inﬂ  uenced 
by the level of patients’ trust in pharmacists.5 From the patients’ perspective, trust in 
pharmacists could be deﬁ  ned as “patients’ willingness to be vulnerable to the actions 
of pharmacists based on the expectation that pharmacists will do what is best for 
patients, irrespective of patients’ ability to monitor pharmacists.”6
Based on a literature search in PubMed (1966–Oct 2006), there was no published 
scale to measure patients’ trust in pharmacists. In order to assess inﬂ  uence of trust on Patient Preference and Adherence 2009:3 2
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other outcomes (ie, adherence to drug therapy, satisfaction 
with the pharmacy service, quality of pharmaceutical 
care, etc.) as demonstrated in studies on other medical prac-
titioners, a reliable and valid instrument to test patients’ trust 
in pharmacists should be developed ﬁ  rst.7–9
Therefore, the primary objective of this study was to 
develop and validate a scale that could measure patients’ 
trust in pharmacists.
As for the scale development, although practical patterns 
are different between pharmacists and other health care prac-
titioners, items and dimensions in trust scales of other health 
care practitioners could still provide useful references. It was 
found that items in the other trust scales could be summed 
into two overarching dimensions as technical competence 
and benevolence.10,11 Technical competence might include 
evaluating problems thoroughly, providing appropriate and 
effective treatment, predisposing factors and structural and 
stafﬁ  ng factors. Benevolence dimension might comprise 
understanding patients’ individual experiences, expressing 
caring, communicating clearly and completely, building 
partnership and sharing power, demonstrating honesty and 
respect, and keeping information conﬁ  dential.8,10–13
In the process of validation, three hypotheses were gen-
erated to test the convergent validity of the scale based on 
ﬁ  ndings from studies on the relationships between patients 
and physicians/other health care practitioners:8,10,11,14
1)  Patients’ trust in pharmacists would be positively correlated 
with “satisfaction with pharmacists’ service”;
2)  Patients’ trust in pharmacists would be positively correlated 
with “returning for care”;
3)  Patients’ trust in pharmacists would be positively correlated 
with “preference of having pharmacists to decide on the 
medication to buy”.
Methods
Study design and subjects
The whole study was divided into two phases: scale develop-
ment and scale validation. No ﬁ  nancial compensation was 
given to any participants in this study and ethics approval 
for the study was obtained from the National University of 
Singapore.
Scale development
Literature review on trust scales in other health care profes-
sions and further study team discussion were carried out to 
identify or generate candidate domains and items that might 
be used to develop the trust scale in pharmacists. Focus group 
approach was then used to determine whether the concept, 
the candidate domains and items based on the literature 
review and study team discussion were relevant, and to 
explore any new candidate domains or items. Apart from 
the open discussion, quantitative methods were also used 
to explore the relevance of those candidate items identiﬁ  ed 
or generated from the literature review and the study team 
discussion. Respondents were asked to rate the relevance of 
those domains and items on a 5-point Likert Scale (1 = least 
relevant, 5 = most relevant).
Eligible participants for the focus group discussion were 
recruited from the batch of ﬁ  nal-year pharmacy undergradu-
ates at the National University of Singapore, who had con-
sulted and obtained medications from pharmacists during 
the past six months before the discussion. The rationale to 
recruit ﬁ  nal-year pharmacy undergraduate students as focus 
group participants was that their valuable experience as intern 
pharmacists could add in the perspective from pharmacists 
as well as third-party observers.
In accordance with rules of thumb, a sample of three to 
four groups with seven people each was planned initially. The 
exact number of groups was determined by the reaching of 
“saturation point”.15 The saturation point was decided to be 
reached if there was no more information/data generated from 
the last two focus group discussions. Focus group discussions 
were audio-recorded and transcribed for content analysis 
using ATLAS.ti 5.0 Demo (ATLAS.ti Scientiﬁ  c Software 
Development GmBh, Berlin, 2003–2005).
Based on the results of the focus group discussions, 
the candidate version of “Trust in Pharmacists Scale” 
was developed. The scale was structured with both favor-
ably and unfavorably worded items to avoid respondents’ 
blind agreement with statements regardless of the con-
tent.16 Answers were formatted with a 7-point Likert scale 
(with −3 = totally disagree and 3 = totally agree) to improve 
score distribution.17 Scores of individual items could be 
summed up for a ﬁ  nal score to represent the level of patients’ 
trust in pharmacists.
The candidate scale was evaluated by 10 other pharmacy 
graduate students for face validity (the relevance to measure 
“patients’ trust in pharmacists”) and clarity of those candidate 
items. An expert panel of three experienced pharmacists was 
asked to assess content validity, that is, how well the candi-
date items represented the speciﬁ  c intended domains based 
on experts’ judgment.18 Pilot testing of the revised candidate 
version was undertaken by a convenience sample of another 
77 ﬁ  nal-year pharmacy undergraduates, who had not partici-
pated in the focus group discussion. Time of completion, 
comments on the revised candidate scale were also collected Patient Preference and Adherence 2009:3 3
Trust in pharmacists scale
to ensure nonexcessive burden on the respondents and to 
provide further suggestions on item modiﬁ  cations.
Scale validation
After necessary amendments, the ﬁ  nalized candidate scale 
was aimed to be distributed by research assistants to a con-
venience sample of 1,200 English-speaking Singaporeans 
at local neighbourhoods and community centers. It was 
designed that study subjects should be across the three 
major local ethnic groups (Chinese, Malay and Indian) from 
three age groups (18–35 yrs; 36–55 yrs; 56 yrs and above) 
with an equal ratio among ethnic groups and 2:2:1 ratio 
among age groups to explore factor structure, reliability 
and validity of the questionnaire. The uneven ratio of age 
groups was due to the fact that the English-speaking elderly 
population is relatively small in Singapore.19 Besides, some 
of the elderly English-speaking population might also have 
cognitive dysfunction due to medical problems or the aging 
process.
Eligible respondents should be able to complete the 
English questionnaire without any help and have consulted 
or obtained medications from a pharmacist during the past 
six months.
Measures
Besides the ﬁ  nalized candidate scale to measure patients’ 
trust in pharmacists, several other questions were included 
in the questionnaire: demographic information (age, gender, 
ethnicity, housing, education level); current chronic disease 
status, basic information relevant to the scale (time period of 
last visit to a pharmacist; type of pharmacist visited last time); 
a validated six-item scale to assess patients’ satisfaction with 
the pharmacists’ service;17 and two newly-generated items 
based on the demonstrated positive association as in earlier 
literatures to assess the behavior intents (willingness to 
return for care on the 7-point Likert scale, preferred decision-
making pattern on medication on a 5-point Likert scale 
[1 = totally by myself, 5 = totally by pharmacist]).20,21
Statistical analysis
Scale development
In the scale development, item means and standard deviations 
were used to quantitatively measure the relevance of those 
candidate items generated from literature review and study 
team discussion by the focus group participants. Item means 
and standard deviations were also used to determine whether 
adequate variability and symmetry in score distribution were 
achieved in the revised candidate scale.
Scale validation
In the scale validation, sample characteristics were descriptively 
analyzed. Response means and standard deviation were cal-
culated to determine variability and symmetry in score distri-
butions, which could indicate discriminatory power. To select 
items for the ﬁ  nal scale, item analyses were done to ensure 
the corrected item–total correlation coefﬁ  cients should be 
greater than 0.30 for ﬁ  nal items.22 Exploratory factor analy-
sis was used to determine dimensions of the trust. Principal 
components analysis of the partial correlation matrix was 
used to identify groups of homogeneous items suitable for 
measuring each dimension of the trust. The number of factors 
selected for Varimax rotation was determined by a combina-
tion of criteria: (1) the roots criterion of selecting factors with 
eigenvalues to be greater than 1; (2) the Scree test to examine 
a plot of eigenvalues and stop factoring at the point where 
the pot begins to level off; and (3) the interpretability and 
meaningfulness of trial factor rotations. Each factor should 
have two or more loadings above 0.40 to make a rotated 
factor interpretable. In addition, the items loading on one 
factor should ﬁ  t together logically.23–26
Tentative scale was then composed of those items with fac-
tor loading above 0.40 on one factor and lesser loadings on other 
factors to represent each dimension. If an item loaded above 
0.40 on more than one factor, assignment of the item was to be 
based on logical ﬁ  t and veriﬁ  cation by item analysis.22,23,25 As 
for reliability, internal consistency was assessed by Cronbach’s 
alpha. Convergent validity was studied using Pearson’s correla-
tion coefﬁ  cients to indicate the association between “patients’ 
trust in pharmacists” with “patients’ satisfaction with pharma-
cists’ service”, “willingness to return for care” and “preferred 
decision-making pattern on medication”.26
Results
Scale development
Altogether four focus groups (total number of  participants = 28) 
were shown to be adequate for item generation. Table 1 
presents the eighteen candidate items that were identiﬁ  ed 
in the literature review, the study team and the focus group 
discussions. It was found that most of the candidate items 
generated from the focus group discussion were the same 
as those identiﬁ  ed from the literature review and the study 
team discussion. Results showed that age, gender, ethnicity 
of pharmacist might be less relevant to patients’ predisposing 
trust in pharmacists than the rest of the items. There were two 
brand new items generated from the focus group discussions: 
type of the pharmacist and set-up of the pharmacy counter. 
Some of the participants thought aloud that they preferred Patient Preference and Adherence 2009:3 4
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hospital pharmacists due to their rich experience with various 
illnesses. Additionally, “a neat and tidy pharmacy counter” 
was regarded as a reﬂ  ection of professionalism and efﬁ  ciency 
of pharmacists. Based on literature review, another item on 
global trust was also included (Item 18 in Table 1).11
The questionnaire was assessed as face valid by the phar-
macy postgraduate students and as content valid by the expert 
panel of pharmacists. In the pilot test, the average completion 
time was 7.4 minutes. Score distribution of the 18 candidate 
items was shown to achieve good variability (SD   1.0) and 
symmetry (means ranged from −1 to 1). In the open-ended 
question on readability of the questionnaire, quite a few respon-
dents suggested to avoid using negative worded items so as to 
minimize confusion. Except for some minor wording changes, 
no other problems were raised. After minor revisions, the scale 
to be validated included 18 revised candidate items (Table 2).
Scale validation
Altogether 2,965 people were approached for the study, 
yet 1,759 of them declined to participate. In the end, the 
questionnaires were distributed to 1,206 eligible respondents 
(response rate = 41%). Data analysis was based on 1,196 
respondents with complete answers on all 18 candidate items 
of the trust scale. Demographic and background information 
was summarized in Table 3.
Item analyses (Table 2) showed that ﬁ  ve candidate items 
(Items 4, 11, 13, 14, and 15) were below the criteria of 0.3 
in item-total correlation, so they were dropped in the ﬁ  rst 
round. When the 13 candidate items were performed using 
the same analysis again, item 10 was found to be below 
the criteria (coefﬁ  cient = 0.12  0.3), leaving 12 items for 
subsequent analyses.22
Based on the criteria of eigenvalue and Scree plot, three 
factors were identiﬁ  ed that accounted for 55% of the total 
variance with the ﬁ  rst factor explaining up to 36%. Two 
items (Items 3 and 5) had dual loadings (loadings greater 
than 0.40 on two factors). Scale assignments for them were 
made on the basis of logical ﬁ  t with other items loading on 
the two factors under consideration. Table 4 lists the factor 
loading and assignment of the 12 ﬁ  nal items.
Table 1 Items generated from focus group approach and response analysis
Items Source* Relevance**
Mean (SD)
1. Demonstrating up-to-date knowledge 3 4.32 (0.72)
2. Evaluating medical problems thoroughly 3 4.36 (0.68)
3. Keeping information totally private (conﬁ  dentiality) 3 4.75 (0.52)
4. Demonstrating honesty when a mistake is made 3 4.32 (0.77)
5. Expressing concern 3 4.43 (0.69)
6. Communicating clearly and completely 3 4.61 (0.50)
7. Showing sufﬁ  cient respect 3 4.57 (0.69)
8. Providing effective medication at a reasonable price 4 4.82 (0.48)




10. Age of the pharmacist 3 2.50 (1.28)
11. Gender of the pharmacist 3 2.25 (1.18)
12. Ethnicity of the pharmacist 1, 4 2.11 (1.10)
13. Type of the pharmacist (Hospital, polyclinic, 
community, etc.)
1 N/A
14. Past experience with pharmacists 4 4.00 (0.90)
15. Recommendation by others (friends, neighbors, 
relatives, etc.)
3 3.68 (0.72)
16. Set-up of the pharmacy counter 1 N/A
17. Professional appearance 3 4.14 (0.71)
18. Global trust in pharmacist 2 N/A
Notes: *1 = generated from focus group only; 2 = generated from literature review only; 3 = both 1 and 2; 4 = generated by the study team only; **Relevance is scored on 
a 5-point Likert scale (1 = most irrelevant; 2 = somewhat irrelevant; 3 = neutral; 4 = somewhat relevant; 5 = most relevant) from 28 participants. Data is presented as mean 
(SD); N/A, not applicable.Patient Preference and Adherence 2009:3 5
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Factors were labeled as follows according to the order 
of extraction: (1) benevolence (including six candidate 
items: conﬁ  dentiality, expressing caring, communicating 
clearly and completely, showing sufﬁ  cient respect, provid-
ing effective medication at a reasonable price and allowing 
shared decision-making pattern when there are alternatives); 
(2) technical competence (including two candidate items: 
demonstrating up-to-date knowledge and evaluating medical 
problem thoroughly); and (3) global trust including all other 
aspects that do not exclusively ﬁ  t in any dimension (including 
four candidate items: blind trust in pharmacists and predis-
posing factors such as recommendation by others, set-up of 
pharmacy counter and professional appearance).8,10–13
Due to the observation that the correlation coefﬁ  cients 
among three factors via Promax rotation were all less than 
0.5, discriminatory power was demonstrated and a three-
dimension scale structure was suggested.24 As shown in 
Table 4, item-scale correlation coefﬁ  cients were between 
0.35 and 0.60. The Cronbach’s alpha was 0.83, indicating high 
internal consistency.27 Convergent validity was demonstrated 
by the ﬁ  nding that, as hypothesized, patients’ trust in pharma-
cists was positively correlated with patients’ satisfaction with 
pharmacists’ service (r = 0.54, P   0.001), returning for care 
(r = 0.30, P   0.001) and preference of having pharmacists to 
decide on the medication to buy (r = 0.16, P   0.001).
Discussion
To the best of our knowledge, the current study was the ﬁ  rst 
one to develop and validate a scale to measure patients’ trust 
in pharmacists. The availability of such scale will enable the 
incorporation of “patients’ trust in pharmacists” as a depen-
dent or an independent variable in pharmacoeconomics and 
pharmaceutical care studies in various health care settings. 
The 12-item scale developed in this study demonstrated high 
reliability and good convergent validity. Systematic approach 
has been adopted to ensure robustness of the results. Scale 
development included item generation (by literature review, 
study team discussion and focus group approach) and item 
Table 2 Item analyses of 18 candidate items
Candidate items Score* Corrected item-total 
correlation coefﬁ  cients
 1.  I trust a pharmacist who has updated knowledge. 1.58 (0.98) 0.39
 2.   I trust the pharmacist if he/she evaluates my medical problem thoroughly. 1.59 (0.99) 0.45
 3.   I trust the pharmacist who could keep the information we discuss totally private. 1.63 (1.05) 0.43
 4.   I trust the pharmacist if he/she tells me about a mistake he/she has made on my 
medication.
0.95 (1.35) 0.28
 5.   I trust the pharmacist if he/she expresses concern and talks to me 
with reassuring and comforting words.
1.47 (0.99) 0.41
 6.   I trust the pharmacist if he/she could communicate with me clearly 
and completely.
1.79 (0.87) 0.46
 7.  I trust a pharmacist who shows sufﬁ  cient respect for me. 1.75 (0.74) 0.43
 8.   I trust the pharmacist if he/she provides me with effective medication 
at a reasonable price to me.
1.60 (1.03) 0.46
 9.   I trust the pharmacist if he/she allows me to make decision on which medication 
to take when there are alternatives.
0.99 (1.19) 0.33
10.  I trust an older pharmacist more than a younger one. 0.44 (1.42) 0.32
11.   I trust a hospital pharmacist more than other types of pharmacist (community, 
polyclinic pharmacist, etc.).
0.31 (1.41) 0.28
12.  I trust a pharmacist with professional appearance. 1.25 (1.07) 0.46
13.   I will trust other pharmacists if I have had pleasant past experience with another 
pharmacist.
0.25 (1.48) 0.14
14.   I trust a pharmacist of the same race as myself more than the other races. −0.51 (1.59) 0.27
15.   I trust a pharmacist of the same gender as myself more than the opposite gender. −0.56 (1.53) 0.19
16.   I trust a pharmacist who has been recommended by others (ie, friends, neighbors 
or relatives, etc.).
1.13 (1.06) 0.39
17.   I trust a pharmacist whose set-up of the counter is neat and tidy. 1.19 (0.95) 0.37
18.   I trust a pharmacist so much that I always try to follow his/her advice. 0.84 (1.14) 0.38
Note: *Score is presented as Mean (SD).Patient Preference and Adherence 2009:3 6
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reﬁ  nement (by panel review and pilot test). Scale validation 
was performed by response analysis, reliability and validity 
tests, and exploratory factor analysis.
Interestingly, the scale to measure patients’ trust in pharma-
cists was shown to have similar dimensionalities to the scale 
to measure patients’ trust in physicians. The two common 
dimensionalities were technical competence and benevolence. 
This would imply that patients tend to trust health care providers 
based on similar criteria. If so, health care providers should espe-
cially put their efforts in improving technical competence and 
showing benevolence to achieve desired treatment outcomes.26 
Apart from the similarity, a difference was also detected in the 
assignment of global trust. Global trust was identiﬁ  ed as an 
independent factor based on the exploratory factor analysis 
in the current scale. Yet, in the scale to measure patients’ trust in 
physicians, it was incorporated into the benevolence factor.11
Additionally, the positive correlations as reported in the 
ﬁ  ndings of convergent validity merit some further discussion. It 
is important and interesting for pharmacists to know that trust 
did play an important part in patients’ satisfaction with their 
services (r = 0.54, p   0.001). As patients’ satisfaction has been 
increasingly emphasized to measure the quality of pharmaceu-
tical care, it is thus essential for pharmacists to understand how 
to gain and improve patients’ trust, which could actually be 
assisted with the use of the current scale.17 Similarly, although 
the correlation between trust and chances of returning for care 
was only mild (r = 0.30, p   0.001), yet it did suggest that trust 
would inﬂ  uence the long-term relationship between pharma-
cists and patients, which has become increasingly important in 
chronic disease management. Comparatively, the correlation 
between trust in pharmacists and preference of having phar-
macists to make the medication decision tended to be much 
milder. This might in fact suggest that patients, especially 
younger generations, might prefer a shared decision-making 
pattern by pharmacists and themselves. This changing para-
digm actually ﬁ  t one of the objectives of disease management, 
that is, patients themselves should play a critical role and be 
more medically knowledgeable.27
Table 3 Demographic and background information of respondents
 N  (%)  unless 




 Chinese 460  (38.5)
 Malay 373  (31.2)
 Indian 363  (30.4)
Housing
  Public housing 927 (77.5)
  Private housing 254 (21.2)
Presence of chronic medical problems 526 (44.0)
Education level
   6 yrs of education 137 (11.5)
  7 to 10 yrs of education 646 (54.0)
   11 yrs of education 394 (32.9)
Last visit to a pharmacist
  Within 1–3 months 671 (56.1)
  Within 4–6 months 525 (43.9)
Type of pharmacist visited last time
 Hospital 294  (24.6)
 Polyclinic 388  (32.4)
 Community 507  (42.4)
Note: *Age is presented as Mean (SD).
Table 4 Factor analysis and reliability of the 12-item trust scale




Factor 1 (benevolence) 3 0.42 0.56 0.81
5 0.46 0.52 0.81
6 0.68 0.60 0.80
7 0.79 0.55 0.81
8 0.73 0.53 0.81
9 0.53 0.36 0.82
Factor 2 (technical competence) 1 0.84 0.52 0.81
2 0.82 0.60 0.80
Factor 3 (global trust) 12 0.62 0.43 0.82
16 0.67 0.35 0.82
17 0.74 0.43 0.82
18 0.59 0.38 0.82Patient Preference and Adherence 2009:3 7
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Several limitations together with suggestions for future 
studies should also be noted:
First, because patients’ trust is a changeable psychologi-
cal trait and not a steady state, retest was not carried out in our 
study.9,28 Therefore, test–retest reliability remains unknown 
for the scale. We suggest that test-retest reliability test be 
assessed in future studies to prove the robustness of the 
scale. In order to minimize the potential change in this psy-
chological trait, we suggest the interval of test-retest should 
be relatively short (eg, one to two weeks) and the participant 
should not have interacted with any other pharmacist during 
the interval. Otherwise, the participant should be excluded 
from the test–retest reliability analysis.
Second, despite potential advantages of thinking of trust 
in perspectives of both patients and pharmacists, ﬁ  nal-year 
pharmacy undergraduates may not well represent pharmacy-
visiting patients in the real world. Hence, it is possible that 
the items generated from those undergraduates might be 
different from patients with diversiﬁ  ed backgrounds. Hence, 
this may potentially affect the validity of the current scale. 
We suggest that in future studies patients with diversiﬁ  ed 
backgrounds be recruited in the focus group discussions to 
further validate the current scale.
Third, due to the convenience sampling and self-
administration mode, respondents of the current study might 
be healthier and better educated compared with the average 
level of pharmacy-visiting patients. Such potential bias may 
lead to different emphasis on the items of trust in pharmacists, 
which may lead to somewhat different chosen items. Hence, 
it is suggested that future study be sampled on a more general 
population to further validate the scale.
In conclusion, the 12-item scale to measure patients’ trust 
in pharmacists demonstrated high reliability and convergent 
validity. It was constructed on three factors, namely, benevo-
lence, technical competence and global trust. Further studies 
with a larger and diverse sample are suggested to conﬁ  rm 
the robustness or even improve the scales. Nevertheless, 
the current scale would provide at least a viable prototype 
for further development of a universally accepted scale to 
measure patients’ trust in pharmacists.
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